Regular blood work during treatment tracks these levels so problems can be caught early
Liu D, Zhou C, Wang X, Luo Z, Xu R, Huo S, et al
[6] [25] At levels only slightly below normal, deficiency can result in fatigue, headaches, feeling faint, rapid breathing, pale skin, numbness or tingling, poor appetite, heartburn, poor balance, difficulty walking, poor reflexes, blurred vision, memory problems, depression, irritability, inattention, cognitive decline, dementia, and even psychosis
Retatrutide is currently in Phase 3 clinical trials and is not yet approved by regulators for public use
10.1186/s13195-021-00779-7 87 GuidoG.ManganoK.TanchevaL.KalfinR.LeoneG
Patients managing insulin resistance, prediabetes, or type 2 diabetes often see added benefits due to improved blood sugar control